Lise M A De Strooper

CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer

C. Meijer, P. Snijders, G. Wisman, 2014, Journal of Clinical Pathology.

Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women

J. Berkhof, C. Meijer, P. Snijders, 2016, Gynecologic oncology.

Methylation Analysis of the FAM19A4 Gene in Cervical Scrapes Is Highly Efficient in Detecting Cervical Carcinomas and Advanced CIN2/3 Lesions

J. Berkhof, C. Meijer, P. Snijders, 2014, Cancer Prevention Research.

Long-term CIN3+ risk of HPV positive women after triage with FAM19A4/miR124-2 methylation analysis.

J. Berkhof, C. Meijer, B. Lissenberg-Witte, 2019, Gynecologic oncology.

Cervical cancer risk in HPV‐positive women after a negative FAM19A4/mir124‐2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow‐up

J. Berkhof, C. Meijer, P. Snijders, 2018, International journal of cancer.

FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women

J. Berkhof, W. Quint, C. Meijer, 2016, British Journal of Cancer.

Management of high-risk HPV-positive women for detection of cervical (pre)cancer

J. Berkhof, C. Meijer, P. Snijders, 2016, Expert review of molecular diagnostics.

Classification of high‐grade cervical intraepithelial neoplasia by p16ink4a, Ki‐67, HPV E4 and FAM19A4/miR124‐2 methylation status demonstrates considerable heterogeneity with potential consequences for management

M. Poljak, J. Berkhof, P. Hillemanns, 2021, International journal of cancer.